Scientific Opinion on Lead in Food

EFSA Journal

Volumn 8, Issue 4, 2010, Pages

[No Author Info available]

Author keywords

adults; children; dietary exposure; food consumption; lead; margin of exposure; occurrence; risk assessment

Indexed keywords

EID: 85029722363     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2010.1570     Document Type: Article

References (397)

1. ACGIH (American Conference of Governmental Industrial Hygienists), 2004. Lead. Threshold limit values for chemical substances and physical agents and biological exposure indices. Cincinnati, OH.
2. Adonaylo VN and Oteiza PI, 1999. Lead intoxication: antioxidant defenses and oxidative damage in rat brain. Toxicology, 135, 77–85.
3. Alexander FW, Clayton BE and Delves HT, 1974. Mineral and trace-metal balances in children receiving normal and synthetic diets. Quarterly Journal of Medicine, 43, 89–111.
4. Alexander J, Aaseth J and Mikalsen A, 1986. Excretion of lead in rat bile-the role of glutathione. Acta Pharmacologica et Toxicologica, 59 Suppl 7, 486–489.
5. Allen JR, McWey PJ and Suomi SJ, 1974. Pathobiological and behavioral effects of lead intoxication in the infant rhesus monkey. Environmental Health Perspectives, 7, 239–246.
6. Almeida AA, Lopes CM, Silva AM and Barrado E, 2008. Trace elements in human milk: correlation with blood levels, inter-element correlations and changes in concentration during the first month of lactation. Journal of Trace Elements in Medicine and Biology, 22, 196–205.
7. Al-Modhefer AJA, Bradbury MWB and Simmons TJB, 1991. Observations on the chemical nature of lead in human blood serum. Clinical Science, 81, 823–829.
8. Altmann L, Weinsberg F, Sveinsson K, Lilienthal H, Wiegand H and Winneke G, 1993. Impairment of long-term potentiation and learning following chronic lead exposure. Toxicology Letters, 66, 105–112.
9. Araki S and Honma T, 1976. Relationships between lead absorption and peripheral nerve conduction velocities in lead workers. Scandinavian Journal of Work, Environment & Health, 2, 225–231.
10. Arrighi HM and Hertz-Picciotto I, 1994. The evolving concept of the healthy worker survivor effect. Epidemiology, 5, 189–196.
11. Astrin KH, Bishop DF, Wetmur JG, Kaul B, Davidow B and Desnick RJ, 1987. Delta-aminolevulinic-acid dehydratase isozymes and lead toxicity. Annals of the New York Academy of Sciences, 514, 23–29.
12. Aufderheide AC and Wittmers LE, 1992. Selected aspects of the spatial-distribution of lead in bone. Neurotoxicology, 13, 809–819.
13. Aungst BJ, Dolce JA and Fung HL, 1981. The effect of dose on the disposition of lead in rats after intravenous and oral-administration. Toxicology and Applied Pharmacology, 61, 48–57.
14. Bacon JR and Dinev NS, 2005. Isotopic characterisation of lead in contaminated soils from the vicinity of a non-ferrous metal smelter near Plovdiv, Bulgaria. Environmental Pollution, 134, 247–255.
15. Bannon DI, Abounader R, Lees PSJ and Bressler JP, 2003. Effect of DMT1 knockdown on iron, cadmium, and lead uptake in Caco-2 cells. American Journal of Physiology-Cell Physiology, 284, C44–C50.
16. Bárány E, Bergdahl IA, Bratteby LE, Lundh T, Samuelson G, Skerfving S and Oskarsson A, 2005. Iron status influences trace element levels in human. Environmental Research, 98, 215–223.
17. Barry PSI, 1975. Comparison of concentrations of lead in human tissues. British Journal of Industrial Medicine, 32, 119–139.
18. Barton JC, Conrad ME, Nuby S and Harrison L, 1978. Effects of iron on the absorption and retention of lead. The Journal of Laboratory and Clinical Medicine, 92, 536–547.
19. Batariova A, Spevackova V, Benes B, Cejchanova M, Smid J and Cerna M, 2006. Blood and urine levels of Pb, Cd and Hg in the general population of the Czech Republic and proposed reference values. International Journal of Hygiene and Environmental Health, 209, 359–366.
20. Battistuzzi G, Petrucci R, Silvagni L, Urbani FR and Caiola S, 1981. Delta-aminolevulinate dehydrase - a new genetic-polymorphism in man. Annals Of Human Genetics, 45, 223–229.
21. Beek B and Obe G, 1974. Effect of lead acetate on human leukocyte chromosomes in vitro. Experientia, 30, 1006–1007.
22. Bergdahl IA, Gerhardsson L, Liljelind IE, Nilsson L and Skerfving S, 2006. Plasma-lead concentration: investigations into its usefulness for biological monitoring of occupational lead exposure. American Journal of Industrial Medicine, 49, 93–101.
23. Bergdahl IA, Gerhardsson L, Schutz A, Desnick RJ, Wetmur JG and Skerfving S, 1997b. Delta-aminolevulinic acid dehydratase polymorphism: Influence on lead levels and kidney function in humans. Archives of Environmental Health, 52, 91–96.
24. Bergdahl IA, Grubb A, Schutz A, Desnick RJ, Wetmur JG, Sassa S and Skerfving S, 1997a. Lead binding to delta-aminolevulinic acid dehydratase (ALAD) in human erythrocytes. Pharmacology & Toxicology, 81, 153–158.
25. Bergdahl IA, Schutz A and Grubb A, 1996. Application of liquid chromatography inductively coupled plasma mass spectrometry to the study of protein-bound lead in human erythrocytes. Journal of Analytical Atomic Spectrometry, 11, 735–738.
26. Bergdahl IA, Sheveleva M, Schutz A, Artamonova VG and Skerfving S, 1998. Plasma and blood lead in humans: Capacity-limited binding to delta-aminolevulinic acid dehydratase and other lead-binding components. Toxicological Sciences, 46, 247–253.
27. Bergdahl IA, Vahter M, Counter SA, Schutz A, Buchanan LH, Ortega F, Laurell G and Skerfving S, 1999. Lead in plasma and whole blood from lead-exposed children. Environmental Research, 80, 25–33.
28. Berkowitz GS, Wolff MS, Lapinski RH and Todd AC, 2004. Prospective study of blood and tibia lead in women undergoing surgical menopause. Environmental Health Perspectives, 112, 1673–1678.
29. Bernard A and Lauwerys R, 1987. Metal-induced alterations of delta-aminolevulinic acid dehydratase. Annals of the New York Academy of Sciences, 514, 41–47.
30. Bernard AM, Vyskocil A, Roels H, Kriz J, Kodl M and Lauwerys R, 1995. Renal effects in children living in the vicinity of a lead smelter. Environmental Research, 68, 91–95.
31. * No. 023/2005 of BfR from 26 March 2004. 12 pp.
32. BfR (Bundesinstitut für Risikobewertung), 2006. Kosmetische Mittel: BfR empfiehlt Schwermetallgehalte über Reinheitsanforderungen der Ausgangsstoffe zu regeln Stellungnahme Nr. 025/2006 des BfR vom 05. April 2006. 4 pp.
33. BfR (Bundesinstitut für Risikobewertung), 2009. Blei und Cadmium gehören nicht in Spielzeug. Stellungnahme Nr. 048/2009 des BfR vom 1. Juni 2009.
34. Blake KCH, Barbezat GO and Mann M, 1983. Effect of dietary constituents on the gastrointestinal absorption of Pb-203 in man. Environmental Research, 30, 182–187.
35. Blake KCH and Mann M, 1983. Effect of calcium and phosphorus on the gastrointestinal absorption of Pb-203 in man. Environmental Research, 30, 188–194.
36. Bolger PM, Carrington CD, Capar SG and Adams MA, 1991. Reductions in dietary lead exposure in the United States. Chem Speciat Bioavail, 3, 31–36.
37. Bolin CM, Basha R, Cox D, Zawia NH, Maloney B, Lahiri DK and Cardozo-Pelaez F, 2006. Exposure to lead and the developmental origin of oxidative DNA damage in the aging brain. FASEB Journal, 20, 788–790.
38. Bonanno LJ, Freeman NCG, Greenberg M and Lioy PJ, 2001. Multivariate analysis on levels of selected metals, particulate matter, VOC, and household characteristics and activities from the Midwestern states NHEXAS. Applied Occupational & Environmental Hygiene, 16, 859–874.
39. Bornschein R, Pearson D and Reiter L, 1980. Behavioral effects of moderate lead exposure in children and animal models: part 2, animal studies. Critical Reviews in Toxicology, 8, 101–152.
40. Boucher O, Muckle G, Saint-Amour D, Dewailly E, Ayotte P, Jacobson SW, Jacobson JL and Bastien CH, 2009. The relation of lead neurotoxicity to the event-related potential P3b component in Inuit children from arctic Quebec. Neurotoxicology, 30, 1070–1077.
41. Bouton CM and Pevsner J, 2000. Effects of lead on gene expression. Neurotoxicology, 21, 1045–1055.
42. Brady J and O'Leary N, 1998. Interference due to haemolysis in routine photometric analysis-a survey. Annals of Clinical Biochemistry, 35 (Pt 1), 128–134.
43. Braun JM, Froehlich TE, Daniels JL, Dietrich KN, Hornung R, Auinger P and Lanphear BP, 2008. Association of environmental toxicants and conduct disorder in U.S. children: NHANES 2001–2004. Environmental Health Perspectives, 116, 956–962.
44. Bressler J, Kim KA, Chakraborti T and Goldstein G, 1999. Molecular mechanisms of lead neurotoxicity. Neurochemical Research, 24, 595–600.
45. Bressler JP and Goldstein GW, 1991. Mechanisms of lead neurotoxicity. Biochemical Pharmacology, 41, 479–484.
46. Brussaard JH, Vandokkum W, Vanderpaauw CG, Devos RH, Dekort W and Lowik MRH, 1996. Dietary intake of food contaminants in the Netherlands (Dutch Nutrition Surveillance System). Food Additives and Contaminants, 13, 561–573.
47. Budtz-J⊘rgensen E, 2010. An international pooled analysis for obtaining a benchmark dose for 2 environmental lead exposure in children. SCIENTIFIC / TECHNICAL REPORT submitted to EFSA. Available from www.efsa.europa.eu
48. Calderon-Salinas JV, Quintanar-Escorcia MA, Gonzalez-Martinez MT and Hernandez-Luna CE, 1999. Lead and calcium transport in human erythrocyte. Human & Experimental Toxicology, 18, 327–332.
49. Canfield RL, Gendle MH and Cory-Slechta DA, 2004. Impaired neuropsychological functioning in lead-exposed children. Developmental Neuropsychology, 26, 513–540.
50. Canfield RL, Henderson CR, Jr., Cory-Slechta DA, Cox C, Jusko TA and Lanphear BP, 2003. Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter. New England Journal of Medicine, 348, 1517–1526.
51. Canfield RL, Kreher DA, Cornwell C and Henderson CR, Jr., 2003a. Low-level lead exposure, executive functioning, and learning in early childhood. Child Neuropsychology, 9, 35–53.
52. Carbone R, Laforgia N, Crollo E, Mautone A and Iolascon A, 1998. Maternal and neonatal lead exposure in southern Italy. Biology of the Neonate, 73, 362–366.
53. Carlisle JC, Dowling KC, Siegel DM and Alexeeff GV, 2009. A blood lead benchmark for assessing risks from childhood lead exposure. J Environ Sci Health A Tox Hazard Subst Environ Eng, 44, 1200–1208.
54. Carlisle JC and Wade MJ, 1992. Predicting blood lead concentrations from environmental concentrations. Regulatory Toxicology and Pharmacology, 16, 280–289.
55. Carmignani M, Boscolo P, Poma A and Volpe AR, 1999. Kininergic system and arterial hypertension following chronic exposure to inorganic lead. Immunopharmacology, 44, 105–110.
56. Carmignani M, Volpe AR, Boscolo P, Qiao N, Di Gioacchino M, Grilli A and Felaco M, 2000. Catecholamine and nitric oxide systems as targets of chronic lead exposure in inducing selective functional impairment. Life Sciences, 68, 401–415.
57. CDC (Centers for Disease Control and Prevention), 1991. Preventing Lead Poisoning in Young Children. Atlanta, GA. Available from www.cdc.gov/nceh/lead/publications/books/plpyc/contents.htm
58. CDC (Centers for Disease Control and Prevention), 2004. Lead poisoning associated with Ayurvedic medications – five states, 2000–2003. MMWR Morb Mortal Weekly Reports. 53, 582–584.
59. CDC (Centers for Disease Control and Prevention), 2005. Preventing Lead Poisoning in Young Children. Atlanta, GA.
60. CDPE (Centers for Disease Prevention and Epidemiology), 1998. Ceramic and pottery cookware: A potential source of Pb. Oregon Health Division. www.oregon.gov/DHS/ph/cdsummary/1998/ohd4721.pdf
61. Cecil KM, Brubaker CJ, Adler CM, Dietrich KN, Altaye M, Egelhoff JC, Wessel S, Elangovan I, Hornung R, Jarvis K and Lanphear BP, 2008. Decreased brain volume in adults with childhood lead exposure. PLoS Med, 5, e112.
62. Celik M, Ekerbicer HC, Ergun UG and Kilinc M, 2007. Effects of environmental lead pollution, smoking, and smokeless tobacco (Maras powder) use on blood lead level. Biological Trace Element Research, 120, 121–126.
63. Chen A, Cai B, Dietrich KN, Radcliffe J and Rogan WJ, 2007. Lead exposure, IQ, and behavior in urban 5- to 7-year-olds: does lead affect behavior only by lowering IQ? Pediatrics, 119, e650–658.
64. Cheng Y, Schwartz J, Sparrow D, Aro A, Weiss ST and Hu H, 2001. Bone lead and blood lead levels in relation to baseline blood pressure and the prospective development of hypertension: the Normative Aging Study. American Journal of Epidemiology, 153, 164–171.
65. Cheng Y, Willet WC, Schwartz J, Sparrow D, Weiss S and Hu H, 1998. Relation of nutrition to bone lead and blood lead levels in middle-aged to elderly men. The Normative Aging Study. American Journal of Epidemiology, 147, 1147–1174.
66. Chiodo LM, Covington C, Sokol RJ, Hannigan JH, Jannise J, Ager J, Greenwald M and Delaney-Black V, 2007. Blood lead levels and specific attention effects in young children. Neurotoxicology and Teratology, 29, 538–546.
67. Choie DD and Richter GW, 1972a. Cell proliferation in rat kidney induced by lead acetate and effects of uninephrectomy on the proliferation. American Journal of Pathology, 66, 265–275.
68. Choie DD and Richter GW, 1972b. Cell proliferation in rat kidneys after prolonged treatment with lead. American Journal of Pathology, 68, 359–370.
69. Cohen AJ and Roe FJC, 1991. Review of lead toxicology relevant to the safety assessment of lead acetate as a hair coloring. Food and Chemical Toxicology, 29, 485–507.
70. Cooper GP, Suszkiw JB and Manalis RS, 1984. Presynaptic effects of heavy metals. In: Cellular and molecular neurotoxicology. T Narahashi. Raven Press, New York, 1–21.
71. Cory-Slechta DA, 1995. Relationships between lead-induced learning impairments and changes in dopaminergic, cholinergic, and glutamatergic neurotransmitter system functions. Annual Review of Pharmacology and Toxicology, 35, 391–415.
72. Cory-Slechta DA, 2003. Lead-induced impairments in complex cognitive function: offerings from experimental studies. Child Neuropsychology, 9, 54–75.
73. Costa LG and Fox DA, 1983. A selective decrease of cholinergic muscarinic receptors in the visual cortex of adult rats following developmental lead exposure. Brain Research, 276, 259–266.
74. COT (Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment), 2008. COT statement on the 2006 UK Total Diet Study of Metals and other Elements.
75. Counter SA, Buchanan LH and Ortega F, 2008. Zinc protoporphyrin levels, blood lead levels and neurocognitive deficits in Andean children with chronic lead exposure. Clinical Biochemistry, 41, 41–47.
76. Dabeka RW and McKenzie AD, 1995. Survey of lead, cadmium, fluoride, nickel, and cobalt in food composites and estimation of dietary intakes of these elements by Canadians in 1986–1988. Journal of AOAC International, 78, 897–909.
77. Dabrowska-Bouta B, Struzynska L, Walski M and Rafalowska U, 2008. Myelin glycoproteins targeted by lead in the rodent model of prolonged exposure. Food and Chemical Toxicology, 46, 961–966.
78. Dabrowska-Bouta B, Sulkowski G, Bartosz G, Walski M and Rafalowska U, 1999. Chronic lead intoxication affects the myelin membrane status in the central nervous system of adult rats. Journal of Molecular Neuroscience, 13, 127–139.
79. De Boer WJ and Van der Voet H, 2007. MCRA, Release 6. A web-based programme for Monte Carlo Risk Assessment. Bilthoven, Wageningen: Biometris, Wageningen UR, RIKILT-Institute of Food Safety, Wageningen UR and National Institute for Public Health and the Environment (RIVM). Available from mcra.rikilt.wur.nl/mcra/Manual.pdf.
80. de Burbure C, Buchet JP, Leroyer A, Nisse C, Haguenoer JM, Mutti A, Smerhovsky Z, Cikrt M, Trzcinka-Ochocka M, Razniewska G, Jakubowski M and Bernard A, 2006. Renal and neurologic effects of cadmium, lead, mercury, and arsenic in children: evidence of early effects and multiple interactions at environmental exposure levels. Environmental Health Perspectives, 114, 584–590.
81. Deknudt G, Colle A and Gerber GB, 1977. Chromosomal abnormalities in lymphocytes from monkeys poisoned with lead. Mutation Research, 45, 77–83.
82. Doss M, von Tiepermann R, Schneider J and Schmid H, 1979. New type of hepatic porphyria with porphobilinogen synthase defect and intermittent acute clinical manifestation. Klinische Wochenschrift, 57, 1123–1127.
83. Doumouchtsis KK, Doumouchtsis SK, Doumouchtsis EK and Perrea DN, 2009. The effect of lead intoxication on endocrine functions. Journal of Endocrinological Investigation, 32, 175–183.
84. Drasch GA, Bohm J and Baur C, 1987. Lead in human bones. Investigations on an occupationally non-exposed population in southern Bavaria (F.R.G.). I. Adults. The Science of The Total Environment, 64, 303–315.
85. Dursun N, Arifoglu C, Süer C and Keskinol L, 2005. Blood pressure relationship to nitric oxide, lipid peroxidation, renal function, and renal blood flow in rats exposed to low lead levels. Biological Trace Element Research, 104, 141–149.
86. EFSA (European Food Safety Authority), 2004. Opinion of the Scientific Panel on Contaminants in the Food Chain (CONTAM) related to leas as undesirable substance in animal feed. EFSA Journal. 71, 1–20.
87. EFSA (European Food Safety Authority), 2005. Guidance of the Scientific Committee on a request from EFSA related to a harmonised approach for risk assessment of substances which are both genotoxic and carcinogenic. The EFSA Journal. 282, 1–31.
88. EFSA (European Food Safety Authority), 2006. Guidance of the Scientific Committee on a request from EFSA related to Uncertainties in Dietary Exposure Assessment. The EFSA Journal. 438, 1–54.
89. EFSA (European Food Safety Authority), 2008. Guidance Document for the use of the Concise European Food Consumption Database in Exposure Assessment. 1–11. Available from www.efsa.europa.eu/cs/BlobServer/General/Coincise_database_guidance_document_and_annexes.pdf?ssbinary=yrue.
90. EFSA (European Food Safety Authority), 2009. Guidance of the Scientific Committee on Use of the benchmark dose approach in risk assessment. The EFSA Journal. 1150, 1–72.
91. Ekong EB, Jaar BG and Weaver VM, 2006. Lead-related nephrotoxicity: a review of the epidemiologic evidence. Kidney International, 70, 2074–2084.
92. Elias Z, Poirot O, Pezerat H, Suquet H, Schneider O, Daniere MC, Terzetti F, Baruthio F, Fournier M and Cavelier C, 1989. Cytotoxic and neoplastic transforming effects of industrial hexavalent chromium pigments in Syrian hamster embryo cells. Carcinogenesis, 10, 2043–2052.
93. EMEP (European Monitoring and Evaluation Programme), 2001. Cyromazine summary report (2). Committee for veterinary medicinal products. European Agency for the Evaluation of medicinal products, veterinary medicines and inspections (EMEA). EMEA/MRL/770/00-FINAL, January 2001. Available from www.emea.europa.eu/pdfs/vet/mrls/077000en.pdf.
94. EMEP/CCC (European Monitoring and Evaluation Programme-Chemical Co-ordinating Centre), 2006. Heavy metals and POP measurements, 2004. Available from tarantula.nilu.no/projects/ccc/reports/cccr7-2006.pdf.
95. Ernst E, 2002. Heavy metals in traditional Indian remedies. European Journal of Clinical Pharmacology, 57, 891–896.
96. Ettinger AS, Tellez-Rojo MM, Amarasiriwardena C, Gonzalez-Cossio T, Peterson KE, Aro A, Hu H and Hernandez-Avila M, 2004. Levels of lead in breast milk and their relation to maternal blood and bone lead levels at one month postpartum. Environmental Health Perspectives, 112, 926–931.
97. Ettinger AS, Tellez-Rojo MM, Amarasiriwardena C, Peterson KE, Schwartz J, Aro A, Hu H and Hernandez-Avila M, 2006. Influence of maternal bone lead burden and calcium intake on levels of lead in breast milk over the course of lactation. American Journal of Epidemiology, 163, 48–56.
98. Evis MJ, Dhaliwal K, Kane KA, Moore MR and Parratt JR, 1987. The effects of chronic lead treatment and hypertension on the severity of cardiac arrhythmias induced by coronary artery occlusion or by noradrenaline in anaesthetised rats. Archives of Toxicology, 59, 336–340.
99. Evis MJ, Kane KA, Moore MR and Parratt JR, 1985. The effects of chronic low lead treatment and hypertension on the severity of cardiac arrhythmias induced by coronary artery ligation in anesthetized rats. Toxicology and Applied Pharmacology, 80, 235–242.
100. Fadrowski JJ, Navas-Acien A, Tellez-Plaza M, Guallar E, Weaver VM and Furth SL, 2010. Blood lead level and kidney function in US adolescents: The Third National Health and Nutrition Examination Survey. Archives of Internal Medicine, 170, 75–82.
101. FAO/WHO (Food and Agriculture Organization/ World Health Organization), 2006. GEMS/Food Consumption Cluster Diets. Available from www.who.int/foodsafety/chem/gems/en/index1.html.
102. Farmand F, Ehdaie A, Roberts CK and Sindhu RK, 2005. Lead-induced dysregulation of superoxide dismutases, catalase, glutathione peroxidase, and guanylate cyclase. Environmental Research, 98, 33–39.
103. Federal Clean Air Act, 1970. 42 United States Code (U.S. C.), § 7401,
104. Fels LM, Wunsch M, Baranowski J, Norska-Borowka I, Price RG, Taylor SA, Patel S, De Broe M, Elsevier MM, Lauwerys R, Roels H, Bernard A, Mutti A, Gelpi E, Rosello J and Stolte H, 1998. Adverse effects of chronic low level lead exposure on kidney function-a risk group study in children. Nephrology, Dialysis, Transplantation, 13, 2248–2256.
105. Fergusson DM, Boden JM and Horwood LJ, 2008. Dentine lead levels in childhood and criminal behaviour in late adolescence and early adulthood. Journal of Epidemiology and Community Health, 62, 1045–1050.
106. Fleming DE, Boulay D, Richard NS, Robin JP, Gordon CL, Webber CE and Chettle DR, 1997. Accumulated body burden and endogenous release of lead in employees of a lead smelter. Environmental Health Perspectives, 105, 224–233.
107. Forbes GB and Reina JC, 1972. Effect of age on gastrointestinal absorption (Fe, Sr, Pb) in the rat. Journal of Nutrition, 102, 647–652.
108. Fowler BA, Kimmel CA, Woods JS, McConnell EE and Grant LD, 1980. Chronic low-level lead toxicity in the rat. III. An integrated assessment of long-term toxicity with special reference to the kidney. Toxicology and Applied Pharmacology, 56, 59–77.
109. Franklin CA, Inskip MJ, Baccanale CL, Edwards CM, Manton WI, Edwards E and O'Flaherty E J, 1997. Use of sequentially administered stable lead isotopes to investigate changes in blood lead during pregnancy in a nonhuman primate (Macaca fascicularis). Fundamental and Applied Toxicology, 39, 109–119.
110. FSA (Food Standards Agency), 2007. Survey of metals in a variety of foods. FSIS 01/07.
111. FSA (Food Standards Agency), 2009. Survey on measurement of the concentrations of metals and other elements from the 2006 UK total diet study. Available from www.food.gov.uk/multimedia/pdfs/fsis0909metals.pdf.
112. Fujita H, Sato K and Sano S, 1982. Increase in the amount of erythrocyte delta-aminolevulinic acid dehydratase in workers with moderate lead exposure. International Archives of Occupational and Environmental Health, 50, 287–297.
113. Gemenetzis P, Moussas P, Arditsoglou A and Samara C, 2006. Mass concentration and elemental composition of indoor PM2.5 and PM10 in university rooms in Thessaloniki, northern Greece. Atmospheric Environment, 40, 3195–3206.
114. Gercken B and Barnes RM, 1991. Determination of lead and other trace-element species in blood by size exclusion chromatography and inductively coupled plasma mass-spectrometry. Analytical Chemistry, 63, 283–287.
115. Gerhardsson L, Kazantzis G and Schutz A, 1996. Evaluation of selected publications on reference values for lead in blood. Scandinavian Journal of Work, Environment & Health, 22, 325–331.
116. Gerhardt RE, Crecelius EA and Hudson JB, 1980. Trace-element content of moonshine. Archives of Environmental Health, 35, 332–334.
117. Gilbert ME and Lasley SM, 2002. Long-term consequences of developmental exposure to lead or polychlorinated biphenyls: Synaptic transmission and plasticity in the rodent CNS. Environmental Toxicology and Pharmacology, 12, 105–117.
118. Glenn BS, Bandeen-Roche K, Lee BK, Weaver VM, Todd AC and Schwartz BS, 2006. Changes in systolic blood pressure associated with lead in blood and bone. Epidemiology, 17, 538–544.
119. Glenn BS, Stewart WF, Links JM, Todd AC and Schwartz BS, 2003. The longitudinal association of lead with blood pressure. Epidemiology, 14, 30–36.
120. Goering PL, 1993. Lead-protein interactions as a basis for lead toxicity. Neurotoxicology, 14, 45–60.
121. Goering PL and Fowler BA, 1985. Mechanism of renal lead-binding protein reversal of delta-aminolevulinic acid dehydratase inhibition by lead. Journal of Pharmacology and Experimental Therapeutics, 234, 365–371.
122. Goldman LS, Genel M, Bezman RJ and Slanetz PJ, 1998. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA: the Journal of the American Medical Association, 279, 1100–1107.
123. Gonick HC, Ding Y, Bondy SC, Ni Z and Vaziri ND, 1997. Lead-induced hypertension: interplay of nitric oxide and reactive oxygen species. Hypertension, 30, 1487–1492.
124. Goyer RA, 1990. Transplacental transport of lead. Environmental Health Perspectives, 89, 101–105.
125. Goyer RA, Leonard DL, Moore JF, Rhyne B and Krigman MR, 1970a. Lead dosage and the role of the intranuclear inclusion body. An experimental study. Archives of Environment Health, 20, 705–711.
126. Goyer RA, May P, Cates MM and Krigman MR, 1970b. Lead and protein content of isolated intranuclear inclusion bodies from kidneys of lead-poisoned rats. Laboratory Investigation, 22, 245–251.
127. Grandjean P and Landrigan PJ, 2006. Developmental neurotoxicity of industrial chemicals. Lancet, 368, 2167–2178.
128. Graziano JH, Popovac D, Factor-Litvak P, Shrout P, Kline J, Murphy MJ, Zhao YH, Mehmeti A, Ahmedi X, Rajovic B, Zvicer Z, Nenezic DU, Lolacono NJ and Stein Z, 1990. Determinants of elevated blood lead during pregnancy in a population surrounding a lead smelter in Kosovo, Yugoslavia. Environmental Health Perspectives, 89, 95–100.
129. Greenberg M and Hamilton R, 1999. Lack of blood lead elevations in police officers following small arms qualification on an indoor range (Abstract). Journal of Toxicology - Clinical Toxicology, 37, 627.
130. Gross SB, Pfitzer EA, Yeager DW and Kehoe RA, 1975. Lead in human tissues. Toxicology and Applied Pharmacology, 32, 638–651.
131. Grosse SD, Matte TD, Schwartz J and Jackson RJ, 2002. Economic gains resulting from the reduction in children's exposure to lead in the United States. Environmental Health Perspectives, 110, 563–569.
132. Gulson B, 2008. Stable lead isotopes in environmental health with emphasis on human investigations. Sci Total Environ, 400, 75–92.
133. Gulson BL, Jameson CW, Mahaffey KR, Mizon KJ, Patison N, Law AJ, Korsch MJ and Salter MA, 1998. Relationships of lead in breast milk to lead in blood, urine, and diet of the infant and mother. Environmental Health Perspectives, 106, 667–674.
134. Gulson BL, Mahaffey KR, Vidal M, Jameson CW, Law AJ, Mizon KJ, Smith AJ and Korsch MJ, 1997. Dietary lead intakes for mother/child pairs and relevance to pharmacokinetic models. Environmental Health Perspectives, 105, 1334–1342.
135. Gulson BL, Mizon KJ, Korsch MJ, Mahaffey KR and Taylor AJ, 2001. Dietary intakes of selected elements from longitudinal 6-day duplicate diets for pregnant and nonpregnant subjects and elemental concentrations of breast milk and infant formula. Environmental Research, 87, 160–174.
136. Gulson BL, Mizon KJ, Korsch MJ, Palmer JM and Donnelly JB, 2003. Mobilization of lead from human bone tissue during pregnancy and lactation-a summary of long-term research. The Science of The Total Environment, 303, 79–104.
137. Gulson BL, Mizon KJ, Palmer JM, Korsch MJ, Taylor AJ and Mahaffey KR, 2004. Blood lead changes during pregnancy and postpartum with calcium supplementation. Environmental Health Perspectives, 112, 1499–1507.
138. Gulson BL, Palmer JM and Bryce A, 2002. Changes in blood lead of a recreational shooter. The Science of The Total Environment, 293, 143–150.
139. Gundacker C, Pietschnig B, Wittmann KJ, Lischka A, Salzer H, Hohenauer L and Schuster E, 2002. Lead and mercury in breast milk. Pediatrics, 110, 873–878.
140. Gunderson EL, 1988. FDA Total Diet Study, April 1982-April 1984, dietary intakes of pesticides, selected elements, and other chemicals. Journal of the Association of Official Analytical Chemists, 71, 1200–1209.
141. Gzyl J, 1995. Ecological impact and remediation of contaminated sites around lead smelters in Poland. Journal of Geochemical Exploration, 52, 251–258.
142. Hänninen H, 1988. The psychological performance profile in occupational intoxications. Neurotoxicology and Teratology, 10, 485–488.
143. Harville EW, Hertz-Picciotto I, Schramm M, Watt-Morse M, Chantala K, Osterloh J, Parsons PJ and Rogan W, 2005. Factors influencing the difference between maternal and cord blood lead. Occupational and Environmental Medicine, 62, 263–269.
144. Heard MJ and Chamberlain AC, 1982. Effect of minerals and food on uptake of lead from the gastrointestinal tract in humans. Human Toxicology, 1, 411–415.
145. HELCOM (Helsinki Commission), 2007. Baltic Marine Environment Protection Commission. HELCOM Indicator Fact Sheets for 2007.
146. Henning SJ and Cooper LC, 1988. Intestinal accumulation of lead salts and milk lead by suckling rats. Proceedings of The Society for Experimental Biology and Medicine, 187, 110–116.
147. Hernandez-Avila M, Smith D, Meneses F, Sanin LH and Hu H, 1998. The influence of bone and blood lead on plasma lead levels in environmentally exposed adults. Environmental Health Perspectives, 106, 473–477.
148. Hernandez-Avila M, Villalpando CG, Palazuelos E, Hu H, Villalpando ME and Martinez DR, 2000. Determinants of blood lead levels across the menopausal transition. Archives of Environment Health, 55, 355–360.
149. Hertz-Picciotto I and Croft J, 1993. Review of the relation between blood lead and blood pressure. Epidemiologic Reviews, 15, 352–373.
150. Hill SJ, 2005. Speciation of Lead. In: Handbook of Elemental Speciation II. R Cornelis, J Caruso, H Crews, K Heumann (eds.). John Wiley & Sons, Chichester, 239–246.
151. Hornung RW, Lanphear BP and Dietrich KN, 2009. Age of greatest susceptibility to childhood lead exposure: a new statistical approach. Environmental Health Perspectives, 117, 1309–1312.
152. Hsiao CY, Wu HD, Lai JS and Kuo HW, 2001. A longitudinal study of the effects of long-term exposure to lead among lead battery factory workers in Taiwan (1989–1999). Sci Total Environ, 279, 151–158.
153. Hsieh LL, Liou SH, Chen YH, Tsai LC, Yang T and Wu TN, 2000. Association between aminolevulinate dehydrogenase genotype and blood lead levels in Taiwan. Journal of Occupational and Environmental Medicine, 42, 151–155.
154. Hu H, Pepper L and Goldman R, 1991. Effect of repeated occupational exposure to lead, cessation of exposure, and chelation on levels of lead in bone. American Journal of Industrial Medicine, 20, 723–735.
155. Hu H, Tellez-Rojo MM, Bellinger D, Smith D, Ettinger AS, Lamadrid-Figueroa H, Schwartz J, Schnaas L, Mercado-Garcia A and Hernandez-Avila M, 2006. Fetal lead exposure at each stage of pregnancy as a predictor of infant mental development. Environmental Health Perspectives, 114, 1730–1735.
156. Hubbs-Tait L, Mulugeta A, Bogale A, Kennedy TS, Baker ER and Stoecker BJ, 2009. Main and interaction effects of iron, zinc, lead, and parenting on children's cognitive outcomes. Developmental Neuropsychology, 34, 175–195.
157. Hursh JB and Mercer TT, 1970. Measurement of Pb-212 loss rate from human lungs. Journal of Applied Physiology, 28, 268–274.
158. Hursh JB, Schraub A, Sattler EL and Hofmann HP, 1969. Fate of 212Pb inhaled by human subjects. Health Physics, 16, 257–267.
159. Hursh JB and Suomela J, 1968. Absorption of 212Pb from the gastrointestinal tract of man. Acta Radiologica: Therapy, Physics, Biology, 7, 108–120.
160. Hwang KY, Schwartz BS, Lee BK, Strickland PT, Todd AC and Bressler JP, 2001. Associations of lead exposure and dose measures with erythrocyte protein kinase C activity in 212 current Korean lead workers. Toxicological Sciences, 62, 280–288.
161. IARC 2006. Inorganic and Organic Lead Compounds. IARC Monographs on the Evaluation of Carcinogenic Risks to Human. 87, 519.
162. Inskip MJ, Franklin CA, Baccanale CL, Manton WI, O'Flaherty EJ, Edwards CM, Blenkinsop JB and Edwards EB, 1996. Measurement of the flux of lead from bone to blood in a nonhuman primate (Macaca fascicularis) by sequential administration of stable lead isotopes. Fundamental and Applied Toxicology, 33, 235–245.
163. IOM (Institute of Medicine), 1991. Nutrition during Lactation. Washington, DC: National Academies Press.
164. Ishihara N and Matsushiro T, 1986. Biliary and urinary-excretion of metals in humans. Archives of Environmental Health, 41, 324–330.
165. Ishihara N, Matsushiro T, Chen ZP and Zhou WS, 1997. Metals in gallstones in Japan and in the Peoples' Republic of China. Trace Elements and Electrolytes, 14, 187–190.
166. Iwata T, Yano E, Karita K, Dakeishi M and Murata K, 2005. Critical dose of lead affecting postural balance in workers. American Journal of Industrial Medicine, 48, 319–325.
167. Jacquet P and Tachon P, 1981. Effects of long-term lead exposure on monkey leukocyte chromosomes. Toxicology Letters, 8, 165–169.
168. James HM, Hilburn ME and Blair JA, 1985. Effects of meals and meal times on uptake of lead from the gastrointestinal tract in humans. Human Toxicology, 4, 401–407.
169. Janakiraman V, Ettinger A, Mercado-Garcia A, Hu H and Hernandez-Avila M, 2003. Calcium supplements and bone resorption in pregnancy: a randomized crossover trial. American Journal of Preventive Medicine, 24, 260–264.
170. JECFA (Joint FAO/WHO Expert Committee on Food Additives), 2000. Summary of Evaluations Performed by the Joint FAO/WHO Expert Committee on Food Additives.
171. Jedrychowski W, Perera F, Jankowski J, Mrozek-Budzyn D, Mroz E, Flak E, Edwards S, Skarupa A and Lisowska-Miszczyk I, 2009. Gender specific differences in neurodevelopmental effects of prenatal exposure to very low-lead levels: the prospective cohort study in three-year olds. Early Human Development, 85, 503–510.
172. Jusko TA, Henderson CR, Lanphear BP, Cory-Slechta DA, Parsons PJ and Canfield RL, 2008. Blood lead concentrations < 10 microg/dL and child intelligence at 6 years of age. Environmental Health Perspectives, 116, 243–248.
173. Kabata-Pendias A and Mukherjeee A, 2007. Trace elements from soil to human. Editor. Springer, 550 pp.
174. Kabata-Pendias A and Pendias H, 1999. Biogeochemistry of trace elements. 2nd edition. Editor. Wyd. Nauk. PWN, Warszawa (in Polish),
175. Kappas A, Sassa S, Galbraith RA and Nordmann Y, 1995. The porphyrias In: The metabolic basis of inherited diseases. !7th ed. CR Scriver, AL Beaudet, WS Sly, Valle D. McGraw-Hill, New York, 2103-2159.
176. Kazi TG, Jalbani N, Arain MB, Jamali MK, Afridi HI and Shah AQ, 2009. Determination of toxic elements in different brands of cigarette by atomic absorption spectrometry using ultrasonic assisted acid digestion. Environmental Monitoring and Assessment, 154, 155–167.
177. Kehoe RA, 1987. Studies of lead administration and elimination in adult volunteers under natural and experimentally induced conditions over extended periods of time. Food and Chemical Toxicology, 25, i-iv, 425-453.
178. Kersting M, Alexy U, Sichert-Hellert W, Manz F and Schoch G, 1998. Measured consumption of commercial infant food products in German infants: Results from the DONALD study. Journal of Pediatric Gastroenterology and Nutrition, 27, 547–552.
179. Khalil-Manesh F, Gonick HC and Cohen AH, 1993. Experimental model of lead nephropathy. III. Continuous low-level lead administration. Archives of Environmental Health, 48, 271–278.
180. Khalil-Manesh F, Gonick HC, Cohen AH, Alinovi R, Bergamaschi E, Mutti A and Rosen VJ, 1992. Experimental model of lead nephropathy. I. Continuous high-dose lead administration. Kidney International, 41, 1192–1203.
181. Kim R, Rotnitsky A, Sparrow D, Weiss S, Wager C and Hu H, 1996. A longitudinal study of low-level lead exposure and impairment of renal function. The Normative Aging Study. JAMA, 275, 1177–1181.
182. Kim Y, Kim BN, Hong YC, Shin MS, Yoo HJ, Kim JW, Bhang SY and Cho SC, 2009. Co-exposure to environmental lead and manganese affects the intelligence of school-aged children. Neurotoxicology, 30, 564–571.
183. Kordas K, Canfield RL, Lopez P, Rosado JL, Vargas GG, Cebrian ME, Rico JA, Ronquillo D and Stoltzfus RJ, 2006. Deficits in cognitive function and achievement in Mexican first-graders with low blood lead concentrations. Environmental Research, 100, 371–386.
184. Korn MG, de Andrade JB, de Jesus DS, Lemos VA, Bandeira ML, Dos Santos WN, Bezerra MA, Amorim FA, Souza AS and Ferreira SL, 2006. Separation and preconcentration procedures for the determination of lead using spectrometric techniques: A review. Talanta, 69, 16–24.
185. Kostial K, Kello D, Jugo S, Rabar I and Maljkovic T, 1978. Influence of age on metal metabolism and toxicity. Environmental Health Perspectives, 25, 81–86.
186. Kramer HJ, Gonick HC and Lu E, 1986. In vitro inhibition of Na-K-ATPase by trace metals: relation to renal and cardiovascular damage. Nephron, 44, 329–336.
187. Krieg EF, Jr., Chrislip DW, Crespo CJ, Brightwell WS, Ehrenberg RL and Otto DA, 2005. The relationship between blood lead levels and neurobehavioral test performance in NHANES III and related occupational studies. Public Health Reports, 120, 240–251.
188. Kristensen P, Eilertsen E, Einarsdottir E, Ovrebo S and Haugen A, 1993. Effect modification by inorganic lead in the dominant lethal assay. Mutation Research, 302, 33–38.
189. Kromhout D, 1988. Blood lead and coronary heart disease risk among elderly men in Zutphen, The Netherlands. Environmental Health Perspectives, 78, 43–46.
190. Kulka E and Gzyl J, 2008. Assessment of lead and cadmium soil contamination in the vicinity of a nonferrous metal smelter. Archives of Environmental Protection, 34, 105–115.
191. Lagerkvist BJ, Ekesrydh S, Englyst V, Nordberg GF, Soderberg HA and Wiklund DE, 1996. Increased blood lead and decreased calcium levels during pregnancy: a prospective study of Swedish women living near a smelter. American Journal of Public Health, 86, 1247–1252.
192. Lai B, Murthy RC, Anand M, Chandra SV, Kumar R, Tripathi O and Srimal RC, 1991. Cardiotoxicity and hypertension in rats after oral lead exposure. Drug and Chemical Toxicology, 14, 305–318.
193. Lakind JS, 1998. Comparison of three models for predicting blood lead levels in children: episodic exposures to lead. Journal of Exposure Analysis and Environmental Epidemiology, 8, 399–406.
194. Landrigan P, Nordberg M, Lucchini R, Nordberg G, Grandjean P, Iregren A and Alessio L, 2006. The Declaration of Brescia on Prevention of the Neurotoxicity of Metals Brescia, Italia 17–18 June 2006. Medicina del Lavoro, 97, 811–814.
195. Lanphear BP, Hornung R, Khoury J, Yolton K, Baghurst P, Bellinger DC, Canfield RL, Dietrich KN, Bornschein R, Greene T, Rothenberg SJ, Needleman HL, Schnaas L, Wasserman G, Graziano J and Roberts R, 2005. Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environmental Health Perspectives, 113, 894–899.
196. Larsen EH, Andersen NL, Moller A, Petersen A, Mortensen GK and Petersen J, 2002. Monitoring the content and intake of trace elements from food in Denmark. Food Additives & Contaminants, 19, 33–46.
197. Larsson B, Slorach SA, Hagman U and Hofvander Y, 1981. WHO collaborative breast-feeding study. 2. Levels of lead and cadmium in Swedish human-milk, 1978–1979. Acta Paediatrica Scandinavica, 70, 281–284.
198. Lasley SM and Gilbert ME, 2000. Glutamatergic components underlying lead-induced impairments in hippocampal synaptic plasticity. Neurotoxicology, 21, 1057–1068.
199. Lauwerys RR and Hoet P, 2001. Industrial chemical exposure. Guidelines for biological monitoring. Editor. Lewis Publishers, CRC Press, Inc., Boca Raton, London, NY, Washington DC, 638 pp.
200. Leblanc JC, Tard A, Volatier JL and Verger P, 2005. Estimated dietary exposure to principal food mycotoxins from the first French Total Diet Study. Food Additives & Contaminants, 22, 652–672.
201. Levey AS, Stevens LA, Schmid CH, Zhang YP, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T and Coresh J, 2009. A New Equation to Estimate Glomerular Filtration Rate. Annals of Internal Medicine, 150, 604–607.
202. Li G, Jiao S, Yin X, Deng Y, Pang X and Wang Y, 2009. The risk of melamine-induced nephrolithiasis in young children starts at a lower intake level than recommended by the WHO. Pediatric Nephrology, 25, 135–141.
203. Li W, Han S, Gregg TR, Kemp FW, Davidow AL, Louria DB, Siegel A and Bogden JD, 2003. Lead exposure potentiates predatory attack behavior in the cat. Environmental Research, 92, 197–206.
204. Lindahl LS, Bird L, Legare ME, Mikeska G, Bratton GR and Tiffany-Castiglioni E, 1999. Differential ability of astroglia and neuronal cells to accumulate lead: dependence on cell type and on degree of differentiation. Toxicological Sciences, 50, 236–243.
205. Llobet JM, Falco G, Casas C, Teixido A and Domingo JL, 2003. Concentrations of arsenic, cadmium, mercury, and lead in common foods and estimated daily intake by children, adolescents, adults, and seniors of Catalonia, Spain. Journal of Agricultural and Food Chemistry, 51, 838–842.
206. Llobet JM, Granero S, Torres A, Schuhmacher M and Domingo JL, 1998. Biological monitoring of environmental pollution and human exposure to metals in Tarragona, Spain. IV. Estimation of the dietary intake. Trace Elements and Electrolytes, 25, 136–141.
207. Maddaloni M, Lolacono N, Manton W, Blum C, Drexler J and Graziano J, 1998. Bioavailability of soilborne lead in adults, by stable isotope dilution. Environmental Health Perspectives, 106 Suppl 6, 1589–1594.
208. Mahaffey KR and Annest JL, 1986. Association of erythrocyte protoporphyrin with blood lead level and iron status in the second National Health and Nutrition Examination Survey, 1976–1980. Environmental Research, 41, 327–338.
209. Maldonado-Vega M, Cerbon-Solorzano J, Albores-Medina A, Hernandez-Luna C and Calderon-Salinas JV, 1996. Lead: intestinal absorption and bone mobilization during lactation. Human & Experimental Toxicology, 15, 872–877.
210. Mameli O, Caria MA, Melis F, Solinas A, Tavera C, Ibba A, Tocco M, Flore C and Sanna Randaccio F, 2001. Neurotoxic effect of lead at low concentrations. Brain Research Bulletin, 55, 269–275.
211. Mannino DM, Albalak RA, Grosse S and Repace J, 2003. Second-hand smoke exposure and blood lead levels in US children. Epidemiology, 14, 719–727.
212. Manton WI, Rothenberg SJ and Manalo M, 2001. The lead content of blood serum. Environmental Research, 86, 263–273.
213. Markovac J and Goldstein GW, 1988. Picomolar concentrations of lead stimulate brain protein kinase C. Nature, 334, 71–73.
214. Martena MJ, Van Der Wielen JCA, Rietjens I, Klerx WNM, De Groot HN and Konings EJM, 2010. Monitoring of mercury, arsenic, and lead in traditional Asian herbal preparations on the Dutch market and estimation of associated risks. Food Additives and Contaminants Part a-Chemistry Analysis Control Exposure & Risk Assessment, 27, 190–205.
215. Marzec Z and Schlegel-Zawadzka M, 2004. Exposure to cadmium, lead and mercury in the adult population from Eastern Poland, 1990–2002. Food Additives and Contaminants, 21, 963–970.
216. Mensink GBM and Beitz R, 2004. Food and nutrient intake in East and West Germany, 8 years after the reunification - The German Nutrition Survey 1998. European Journal of Clinical Nutrition, 58, 1000–1010.
217. Meyer-Baron M and Seeber A, 2000. A meta-analysis for neurobehavioural results due to occupational lead exposure with blood lead concentrations <70 microg/100 ml. Archives of Toxicology, 73, 510–518.
218. Mielke HW, Dugas D, Mielke PW, Jr., Smith KS and Gonzales CR, 1997. Associations between soil lead and childhood blood lead in urban New Orleans and rural Lafourche Parish of Louisiana. Environmental Health Perspectives, 105, 950–954.
219. Millot R, Allegre CJ, Gaillardet J and Roy S, 2004. Lead isotopic systematics of major river sediments: a new estimate of the Pb isotopic composition of the Upper Continental Crust. Chemical Geology, 203, 75–90.
220. Min JY, Min KB, Cho SI, Kim R, Sakong J and Paek D, 2007. Neurobehavioral function in children with low blood lead concentrations. Neurotoxicology, 28, 421–425.
221. Min MO, Singer LT, Kirchner HL, Minnes S, Short E, Hussain Z and Nelson S, 2009. Cognitive development and low-level lead exposure in poly-drug exposed children. Neurotoxicology and Teratology, 31, 225–231.
222. Miranda ML, Kim D, Galeano MA, Paul CJ, Hull AP and Morgan SP, 2007. The relationship between early childhood blood lead levels and performance on end-of-grade tests. Environmental Health Perspectives, 115, 1242–1247.
223. Mishra VK, Kim KH, Kang CH and Choi KC, 2004. Wintertime sources and distribution of airborne lead in Korea. Atmospheric Environment, 38, 2653–2664.
224. Moldoon SB, Cauley JA, JKuller LH, Morrow LA, Needleman HL, Scott J and F.J. H, 1996. Effects of blood lead levels on cognitive function of older women. Neuroepidemiology, 15, 62–72.
225. M⊘ller L and Kristensen TS, 1992. Blood lead as a cardiovascular risk factor. American Journal of Epidemiology, 136, 1091–1100.
226. Moore JF, Goyer RA and Wilson M, 1973. Lead-induced inclusion bodies. Solubility, amino acid content, and relationship to residual acidic nuclear proteins. Laboratory Investigation, 29, 488–494.
227. Moore MR, Meredith PA, Watson WS, Sumner DJ, Taylor MK and Goldberg A, 1980. The percutaneous absorption of lead-203 in humans from cosmetic preparations containing lead acetate, as assessed by whole-body counting and other techniques. Food and Cosmetics Toxicology, 18, 399–405.
228. Moreiras O and Cuadrado C, 1992. Theoretical-study of the intake of trace-elements (nutrients and contaminants) via total diet in some geographical areas of Spain. Biological Trace Element Research, 32, 93–103.
229. Morrison JN and Quarterman J, 1987. The relationship between iron status and lead absorption in rats. Biological Trace Element Research, 14, 115–126.
230. Morrow PE, Beiter H, Amato F and Gibb FR, 1980. Pulmonary retention of lead: an experimental study in man. Environmental Research, 21, 373–384.
231. Morton MJ and Laffoon SW, 2008. Cigarette smoke chemistry market maps under Massachusetts Department of Public Health smoking conditions. Regulatory Toxicology and Pharmacology, 51, 1–30.
232. Mostafa GA, El-Shahawi HH and Mokhtar A, 2009. Blood lead levels in Egyptian children from high and low lead-polluted areas: impact on cognitive function. Acta Neurologica Scandinavica, 120, 30–37.
233. Muntner P, He J, Vupputuri S, Coresh J and Batuman V, 2003. Blood lead and chronic kidney disease in the general United States population: results from NHANES III. Kidney International, 63, 1044–1050.
234. Muntner P, Menke A, DeSalvo KB, Rabito FA and Batuman V, 2005. Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys. Archives of Internal Medicine, 165, 2155–2161.
235. Murata K, Iwata T, Dakeishi M and Karita K, 2009. Lead toxicity: does the critical level of lead resulting in adverse effects differ between adults and children? Journal of Occupational Health, 51, 1–12.
236. Murray K, Bazzi A, Carter C, Ehlert A, Harris A, Kopec M, Richardson J and Sokol H, 1997. Distribution and mobility of lead in soils at an outdoor shooting range. Journal of Soil Contamination, 6, 79–93.
237. Mykkänen HM and Wasserman RH, 1981. Gastrointestinal absorption of lead (203Pb) in chicks: influence of lead, calcium, and age. Journal of Nutrition, 111, 1757–1765.
238. Mykkänen HM and Wasserman RH, 1982. Effect of vitamin D on the intestinal absorption of 203Pb and 47Ca in chicks. Journal of Nutrition, 112, 520–527.
239. Namihira D, Saldivar L, Pustilnik N, Carreon GJ and Salinas ME, 1993. Lead in human blood and milk from nursing women living near a smelter in Mexico City. Journal of Toxicology and Environment Health, 38, 225–232.
240. Nash D, Magder L, Lustberg M, Sherwin RW, Rubin RJ, Kaufmann RB and Silbergeld EK, 2003. Blood lead, blood pressure, and hypertension in perimenopausal and postmenopausal women. JAMA, 289, 1523–1532.
241. Nash D, Magder LS, Sherwin R, Rubin RJ and Silbergeld EK, 2004. Bone density-related predictors of blood lead level among peri- and postmenopausal women in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994. American Journal of Epidemiology, 160, 901–911.
242. Navas-Acien A, Tellez-Plaza M, Guallar E, Muntner P, Silbergeld E, Jaar B and Weaver V, 2009. Blood cadmium and lead and chronic kidney disease in US adults: a joint analysis. American Journal of Epidemiology, 170, 1156–1164.
243. Nawrot TS, Thijs L, Den Hond EM, Roels HA and Staessen JA, 2002. An epidemiological reappraisal of the association between blood pressure and blood lead: a meta-analysis. Journal of Human Hypertension, 16, 123–131.
244. Newland MC, Yezhou S, Logdberg B and Berlin M, 1994. Prolonged behavioral effects of in utero exposure to lead or methyl mercury: reduced sensitivity to changes in reinforcement contingencies during behavioral transitions and in steady state. Toxicology and Applied Pharmacology, 126, 6–15.
245. Ni Z, Hou S, Barton CH and Vaziri ND, 2004. Lead exposure raises superoxide and hydrogen peroxide in human endothelial and vascular smooth muscle cells. Kidney International, 66, 2329–2336.
246. Nigg JT, Knottnerus GM, Martel MM, Nikolas M, Cavanagh K, Karmaus W and Rappley MD, 2008. Low blood lead levels associated with clinically diagnosed attention-deficit/hyperactivity disorder and mediated by weak cognitive control. Biological Psychiatry, 63, 325–331.
247. Nihei MK and Guilarte TR, 2002. Molecular mechanisms of low-level Pb2+ neurotoxicity. In: Handbook of neurotoxicology. EJ Massaro. Humana Press, Totowa, NJ, 107–133.
248. NTP (National Toxicology Programme), 2004. Lead (CAS No 7439–92-1) and lead compounds. In: Report on carcinogens. 11th ed. Research Triangle Park: US Department of Health and Human Services. Available from ntp.niehs.nih.gov/ntp/roc/eleventh/profiles/s101lead.pdf.
249. OECD (Organization for Economic Cooperation and Development), 1993. Risk Reduction Monograph No. 1 Lead Background And National Experience With Reducing Risk. Paris. 1-295.
250. O'Flaherty EJ, 1995. Physiologically-based models for bone-seeking elements. 5. Lead absorption and disposition in childhood. Toxicology and Applied Pharmacology, 131, 297–308.
251. O'Flaherty EJ, Hammond PB and Lerner SI, 1982. Dependence of apparent blood lead half-life on the length of previous lead exposure in humans. Fundamental and Applied Toxicology, 2, 49–54.
252. Ong CN and Lee WR, 1980. High affinity of lead for fetal haemoglobin. British Journal of Industrial Medicine, 37, 292–298.
253. Onyango AW, Receveur O and Esrey SA, 2002. The contribution of breast milk to toddler diets in western Kenya. Bulletin of The World Health Organization, 80, Available from www.who.int/bulletin/archives/80(84)292.pdf.
254. Oskarsson A and Fowler BA, 1985. Effects of lead inclusion bodies on subcellular distribution of lead in rat kidney: the relationship to mitochondrial function. Experimental and Molecular Pathology, 43, 397–408.
255. OSPAR (The Convention for the Protection of the Marine Environment of the North-East Atlantic), 2009. Background document on lead. Hazardous Substances Series. 28 pp.
256. Pacyna JM and Pacyna EG, 2001. An assessment of global and regional emissions of trace metals to the atmosphere from anthropogenic sources worldwide. Environmental Reviews, 9, 269–298.
257. Pacyna JM, Pacyna EG and Aas W, 2009. Changes of emissions and atmospheric deposition of mercury, lead, and cadmium. Atmospheric Environment, 43, 117–127.
258. Patel A, Mamtani MR, Thakre TP and Kulkarni H, 2006. Association of umbilical cord lead with neonatal behaviour at varying levels of exposure. Behavioral and Brain Functions, 2, 1–12.
259. Payton M, Riggs KM, Spiro A, 3rd Weiss ST and Hu H, 1998. Relations of bone and blood lead to cognitive function: the VA Normative Aging Study. Neurotoxicology and Teratology, 20, 19–27.
260. Perry HM, Jr., Erlanger MW and Perry EF, 1988. Increase in the blood pressure of rats chronically fed low levels of lead. Environmental Health Perspectives, 78, 107–111.
261. Piccinini F, Favalli L and Chiari MC, 1977. Experimental investigations on the contraction induced by lead in arterial smooth muscle. Toxicology, 8, 43–51.
262. Plusquellec P, Muckle G, Dewailly E, Ayotte P, Jacobson SW and Jacobson JL, 2007. The relation of low-level prenatal lead exposure to behavioral indicators of attention in Inuit infants in Arctic Quebec. Neurotoxicology and Teratology, 29, 527–537.
263. Pocock SJ, Shaper AG, Ashby D, Delves HT and Clayton BE, 1988. The relationship between blood lead, blood pressure, stroke, and heart attacks in middle-aged British men. Environmental Health Perspectives, 78, 23–30.
264. Pocock SJ, Shaper AG, Ashby D, Delves T and Whitehead TP, 1984. Blood lead concentration, blood pressure, and renal function. British Medical Journal (Clinical Research Ed.), 289, 872–874.
265. Popovic M, McNeill FE, Chettle DR, Webber CE, Lee CV and Kaye WE, 2005. Impact of occupational exposure on lead levels in women. Environmental Health Perspectives, 113, 478–484.
266. Pounds JG, Marlar RJ and Allen JR, 1978. Metabolism of lead-210 in juvenile and adult rhesus monkeys (Macaca mulatta). Bulletin of Environment Contamination and Toxicology, 19, 684–691.
267. Pruvot C, Douay F, Herve F and Waterlot C, 2006. Heavy metals in soil, crops and grass as a source of human exposure in the former mining areas. Journal of Soils and Sediments, 6, 215–220.
268. Rabinowitz MB, 1991. Toxicokinetics of bone lead. Environmental Health Perspectives, 91, 33–37.
269. Rabinowitz MB, Kopple JD and Wetherill GW, 1980. Effect of food intake and fasting on gastrointestinal lead absorption in humans. American Journal of Clinical Nutrition, 33, 1784–1788.
270. Rabinowitz MB, Wetherill GW and Kopple JD, 1976. Kinetic-analysis of lead metabolism in healthy humans. Journal of Clinical Investigation, 58, 260–270.
271. Rhodes D, Spiro A, 3rd Aro A and Hu H, 2003. Relationship of bone and blood lead levels to psychiatric symptoms: the normative aging study. Journal of Occupational and Environmental Medicine, 45, 1144–1151.
272. Rice DC, 1985. Chronic low-lead exposure from birth produces deficits in discrimination reversal in monkeys. Toxicology and Applied Pharmacology, 77, 201–210.
273. Rice DC, 1990. Lead-induced behavioral impairment on a spatial discrimination reversal task in monkeys exposed during different periods of development. Toxicology and Applied Pharmacology, 106, 327–333.
274. Richter PA, Bishop EE, Wang JT and Swahn MH, 2009. Tobacco Smoke Exposure and Levels of Urinary Metals in the US Youth and Adult Population: The National Health and Nutrition Examination Survey (NHANES) 1999–2004. International Journal of Environmental Research and Public Health, 6, 1930–1930.
275. Rickert WS and Kaiserman MJ, 1994. Levels of lead, cadmium, and mercury in Canadian cigarette tobacco as indicators of environmental-change - results from a 21-year study (1968–1988). Environmental Science & Technology, 28, 924–927.
276. Rischitelli G, Nygren P, Bougatsos C, Freeman M and Helfand M, 2006. Screening for elevated lead levels in childhood and pregnancy: an updated summary of evidence for the US Preventive Services Task Force. Pediatrics, 118, e1867–1895.
277. Rodríguez-Ortíz JC, Valdez-Cepeda RD, Lara-Mireles JL, Rodrígues-Fuentes H, Vázquez-Alvarado RE, Magallanes-Quintanar R and García-Hernández JL, 2006. Soil Nitrogen Fertilization Effects on Phytoextraction of Cadmium and Lead by Tobacco (Nicotiana tabacum L.). Bioremediation Journal, 10, 105–114.
278. Roels H, Lauwerys R, Konings J, Buchet JP, Bernard A, Green S, Bradley D, Morgan W and Chettle D, 1994. Renal function and hyperfiltration capacity in lead smelter workers with high bone lead. Occupational and Environmental Medicine, 51, 505–512.
279. Roy A, Bellinger D, Hu H, Schwartz J, Ettinger AS, Wright RO, Bouchard M, Palaniappan K and Balakrishnan K, 2009. Lead exposure and behavior among young children in Chennai, India. Environmental Health Perspectives, 117, 1607–1611.
280. Sakai T, Yanagihara S, Kunugi Y and Ushio K, 1982. Relationships between distribution of lead in erythrocytes in vivo and in vitro and inhibition of ALA-D. British Journal of Industrial Medicine, 39, 382–387.
281. Sakai T, Yanagihara S, Kunugi Y and Ushio K, 1983. Mechanisms of ALA-D inhibition by lead and of its restoration by zinc and dithiothreitol. British Journal of Industrial Medicine, 40, 61–66.
282. Sand S, von Rosen D, Victorin K and Filipsson AF, 2006. Identification of a critical dose level for risk assessment: developments in benchmark dose analysis of continuous endpoints. Toxicological Sciences, 90, 241–251.
283. SCCNFP (The Scientific Committee on Cosmetic Products and Non-Food Products Intended for Consumers), 2004. Opinion concerning lead acetate. SCCNFP/0832/04. 2 pp. Available from ec.europa.eu/health/ph_risk/committees/sccp/documents/out286_en.pdf.
284. SCF (Scientific Committee on Food), 1992. Opinion of 19 June 1992, Thirty second series, 1994, p. 7. Available from ec.europa.eu/food/fs/sc/scf/reports/scf_reports_32.pdf.
285. Schmidt U and Huber F, 1976. Methylation of organolead and lead(II) compounds to (CH3)4Pb by microorganisms. Nature, 259, 157–158.
286. Schnaas L, Rothenberg SJ, Flores MF, Martinez S, Hernandez C, Osorio E, Velasco SR and Perroni E, 2006. Reduced intellectual development in children with prenatal lead exposure. Environmental Health Perspectives, 114, 791–797.
287. Schober SE, Mirel LB, Graubard BI, Brody DJ and Flegal KM, 2006. Blood lead levels and death from all causes, cardiovascular disease, and cancer: results from the NHANES III mortality study. Environmental Health Perspectives, 114, 1538–1541.
288. Schuhmacher M, Hernandez M, Domingo JL, FernandezBallart JD, Llobet JM and Corbella J, 1996. A longitudinal study of lead mobilization during pregnancy: Concentrations in maternal and umbilical cord blood. Trace Elements and Electrolytes, 13, 177–181.
289. Schulz C, Angerer J, Ewers U, Heudorf U and Wilhelm M, 2009. Revised and new reference values for environmental pollutants in urine or blood of children in Germany derived from the German environmental survey on children 2003–2006 (GerES IV). International Journal of Hygiene and Environmental Health, 212, 637–647.
290. Schutz A, Bergdahl IA, Ekholm A and Skerfving S, 1996. Measurement by ICP-MS of lead in plasma and whole blood of lead workers and controls. Occupational and Environmental Medicine, 53, 736–740.
291. Schwartz BS, Lee BK, Bandeen-Roche K, Stewart W, Bolla K, Links J, Weaver V and Todd A, 2005. Occupational lead exposure and longitudinal decline in neurobehavioral test scores. Epidemiology, 16, 106–113.
292. Schwartz BS, Stewart WF, Bolla KI, Simon PD, Bandeen-Roche K, Gordon PB, Links JM and Todd AC, 2000. Past adult lead exposure is associated with longitudinal decline in cognitive function. Neurology, 55, 1144–1150.
293. Schwartz J, 1988. The relationship between blood lead and blood pressure in the NHANES II survey. Environmental Health Perspectives, 78, 15–22.
294. Schwartz J, 1994. Societal benefits of reducing lead exposure. Environmental Research, 66, 105–124.
295. Schwartz J, 1995. Lead, blood pressure, and cardiovascular disease in men. Archives of Environment Health, 50, 31–37.
296. SCOOP (Scientific Cooperation), 2004. SCOOP Report of experts participating in Task 3.2.11. March 2004. Assessment of the dietary exposure to arsenic, cadmium, lead and mercury of the population of the EU Member States. 125 pp.
297. Selmer RM, Kristiansen IS, Haglerod A, Graff-Iversen S, Larsen HK, Meyer HE, Bonaa KH and Thelle DS, 2000. Cost and health consequences of reducing the population intake of salt. Journal of Epidemiology and Community Health, 54, 697–702.
298. Seppáláinen AM, Hernberg S and Kock B, 1979. Relationship between blood lead levels and nerve-conduction velocities. Neurotoxicology, 1, 313–332.
299. Shih RA, Glass TA, Bandeen-Roche K, Carlson MC, Bolla KI, Todd AC and Schwartz BS, 2006. Environmental lead exposure and cognitive function in community-dwelling older adults. Neurology, 67, 1556–1562.
300. Shih RA, Hu H, Weisskopf MG and Schwartz BS, 2007. Cumulative lead dose and cognitive function in adults: a review of studies that measured both blood lead and bone lead. Environmental Health Perspectives, 115, 483–492.
301. Shih TM and Hanin I, 1978. Effects of chronic lead exposure on levels of acetylcholine and choline and on acetylcholine turnover rate in rat brain areas in vivo. Psychopharmacology (Berl), 58, 263–269.
302. Sidhu MK, Fernandez C, Khan MY and Kumar S, 1991. Induction of morphological transformation, anchorage-independent growth and plasminogen activators in non-tumorigenic human osteosarcoma cells by lead chromate. Anticancer Research, 11, 1045–1053.
303. Sidhu P and Nehru B, 2003. Relationship between lead-induced biochemical and behavioral changes with trace element concentrations in rat brain. Biological Trace Element Research, 92, 245–256.
304. Silbergeld EK, 1977. Interactions of lead and calcium on the synaptosomal uptake of dopamine and choline. Life Sciences, 20, 309–318.
305. Silbergeld EK, Waalkes M and Rice JM, 2000. Lead as a carcinogen: experimental evidence and mechanisms of action. American Journal of Industrial Medicine, 38, 316–323.
306. Simons TJ, 1985. Influence of lead ions on cation permeability in human red cell ghosts. Journal of Membrane Biology, 84, 61–71.
307. Simons TJ, 1986a. The role of anion transport in the passive movement of lead across the human red cell membrane. The Journal of Physiology, 378, 287–312.
308. Simons TJ, 1986b. Passive transport and binding of lead by human red blood cells. The Journal of Physiology, 378, 267–286.
309. Simons TJ, 1988. Active transport of lead by the calcium pump in human red cell ghosts. The Journal of Physiology, 405, 105–113.
310. Simons TJ, 1993. Lead transport and binding by human erythrocytes in vitro. Pflugers Archiv. European Journal of Physiology, 423, 307–313.
311. Six KM and Goyer RA, 1970. Experimental enhancement of lead toxicity by low dietary calcium. The Journal of Laboratory and Clinical Medicine, 76, 933–942.
312. Skerfving S and Bergdahl IA, 2007. Lead. In: Handbook on the toxicology of metals, 3rd edition. GF Nordberg, BA Fowler, M Nordberg, LT Friberg (eds.). Elsevier, 599–643.
313. Skjelkvale BL and Traaen TS, 2003. Heavy metals in surface waters; results from ICP Waters. In: ICP waters Report, 73/2003. Convention on Long-range Transboundary Air Pollution. International Cooperative Programme on Assessment and Monitoring of Acidification of Rivers and Lakes. The 15-year report: Assessment and monitoring of surface waters in Europe and North America; acidification and recovery, dynamic modelling and heavy metals. Norwegian Institute for Water Research NIVA.
314. Slezakova K, Pereira MC and Alvim-Ferraz MC, 2009. Influence of tobacco smoke on the elemental composition of indoor particles of different sizes. Atmospheric Environment, 43, 486–493.
315. Slob W, 2006. Probabilistic dietary exposure assessment taking into account variability in both amount and frequency of consumption. Food and Chemical Toxicology, 44, 933–951.
316. Smith D, Hernandez-Avila M, Tellez-Rojo MM, Mercado A and Hu H, 2002. The relationship between lead in plasma and whole blood in women. Environmental Health Perspectives, 110, 263–268.
317. Smith DR, Kahng MW, Quintanilla-Vega B and Fowler BA, 1998. High-affinity renal lead-binding proteins in environmentally-exposed humans. Chemico-Biological Interactions, 115, 39–52.
318. Smith DR, Osterloh JD and Flegal AR, 1996. Use of endogenous, stable lead isotopes to determine release of lead from the skeleton. Environmental Health Perspectives, 104, 60–66.
319. Solon O, Riddell J, Quimbo SA, Butrick E, Aylward GP, Bacate ML and Peabody JW, 2008. Associations between congnitive function, blood lead concentration, and nutrition among children in the Central Philippines. The Journal of Pediatrics, 152, 237–243.
320. Staessen JA, Bulpitt CJ, Fagard R, Lauwerys RR, Roels H, Thijs L and Amery A, 1994. Hypertension caused by low-level lead exposure: myth or fact? Journal of Cardiovascular Risk, 1, 87–97.
321. Staessen JA, Lauwerys RR, Buchet JP, Bulpitt CJ, Rondia D, Vanrenterghem Y and Amery A, 1992. Impairment of renal function with increasing blood lead concentrations in the general population. The Cadmibel Study Group. The New England Journal of Medicine, 327, 151–156.
322. Stauber JL, Florence TM, Gulson BL and Dale LS, 1994. Percutaneous absorption of inorganic lead compounds. Science of the Total Environment, 145, 55–70.
323. Sternowsky HJ and Wessolowski R, 1985. Lead and cadmium in breast-milk - higher levels in urban vs rural mothers during the 1st 3 months of lactation. Archives of Toxicology, 57, 41–45.
324. Stohs SJ and Bagchi D, 1995. Oxidative mechanisms in the toxicity of metal ions. Free Radical Biology & Medicine, 18, 321–336.
325. Stowe HD, Goyer RA, Krigman M, Wilson M and Cates M, 1973. Experimental oral lead toxicity in young dogs. Clinical and morphologic effects. Archives of Pathology, 95, 106–116.
326. Surkan PJ, Zhang A, Trachtenberg F, Daniel DB, McKinlay S and Bellinger DC, 2007. Neuropsychological function in children with blood lead levels <10 microg/dL. Neurotoxicology, 28, 1170–1177.
327. Suszkiw J, Toth G, Murawsky M and Cooper GP, 1984. Effects of Pb2+ and Cd2+ on acetylcholine release and Ca2+ movements in synaptosomes and subcellular fractions from rat brain and Torpedo electric organ. Brain Research, 323, 31–46.
328. Suszkiw JB, 2004. Presynaptic disruption of transmitter release by lead. Neurotoxicology, 25, 599–604.
329. Tahvonen R, 1997. Contents of lead in foods and diet in Finland in the early 1990s. Food Reviews International, 13, 77–90.
330. Tait PA, Vora A, James S, Fitzgerald DJ and Pester BA, 2002. Severe congenital lead poisoning in a preterm infant due to a herbal remedy. Medical Journal of Australia, 177, 193–195.
331. Tellez-Rojo MM, Bellinger DC, Arroyo-Quiroz C, Lamadrid-Figueroa H, Mercado-Garcia A, Schnaas-Arrieta L, Wright RO, Hernandez-Avila M and Hu H, 2006. Longitudinal associations between blood lead concentrations lower than 10 microg/dL and neurobehavioral development in environmentally exposed children in Mexico City. Pediatrics, 118, e323–330.
332. Thomas KW, Pellizzari ED and Berry MR, 1999. Population-based dietary intakes and tap water concentrations for selected elements in the EPA Region V National Human Exposure Assessment Survey (NHEXAS). Journal of Exposure Analysis and Environmental Epidemiology, 9, 402–413.
333. Toscano CD and Guilarte TR, 2005. Lead neurotoxicity: from exposure to molecular effects. Brain Research. Brain Research Reviews, 49, 529–554.
334. Treble RG and Thompson TS, 1997. Preliminary results of a survey of lead levels in human liver tissue. Bulletin of Environment Contamination and Toxicology, 59, 688–695.
335. Tsaih SW, Korrick S, Schwartz J, Amarasiriwardena C, Aro A, Sparrow D and Hu H, 2004. Lead, diabetes, hypertension, and renal function: the normative aging study. Environmental Health Perspectives, 112, 1178–1182.
336. Tsoumbaris P and Tsoukali-Papadopoulou H, 1994. Heavy-metals in common foodstuff - quantitative-analysis. Bulletin of Environmental Contamination and Toxicology, 53, 61–66.
337. Tukker A, Buijst H, van Oers L and van der Voet E, 2001. Risks to health and the environment related to the use of lead in products. TNO Report STB-01-39 for the European Commission. Brussels, Directorate General Enterprise.
338. Turrini A and Lombardi-Boccia G, 2002. The formulation of the market basket of the Italian total diet 1994–96. Nutrition Research, 22, 1151–1162.
339. Turrini A, Saba A, Perrone D, Cialfa E and D'Amicis A, 2001. INN-CA (Nationwide Nutritional Survey of Food Behaviour). Food consumption patterns in Italy: the INN-CA Study 1994–1996. European Journal of Clinical Nutrition, 55, 571–588.
340. UNEP (United Nations Environment Programme), 2008. Interim review of scientific information on lead. Version of March 2008.
341. US ATSDR (United States Agency for Toxic Substances and Disease Registry), 2007. Toxicological Profile for lead. U.S. Department of Health and Human Services. 1–582.
342. US EPA (U.S. Environmental Protection Agency), 1973. EPA Requires Phase-Out of Lead in All Grades of Gasoline [EPA press release - November 28, 1973].
343. US EPA (U.S. Environmental Protection Agency), 1977. Control techniques for Lead Air Emissions. Office of Air Quality Planning and Standards. EPA-450/2-77-012. Research Triangle Park, N.C.
344. US EPA (U.S. Environmental Protection Agency), 1985. Lead exposures in the human environment. Research Triangle Park, NC: U.S. Environmental Protection Agency, Environmental Criteria and Assessment Office. EPA600D86185, PB86241007.
345. US EPA (U.S. Environmental Protection Agency), 1986. Air quality criteria for lead. Office of Research and Development, Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office. EPA600883028F,
346. US EPA (U.S. Environmental Protection Agency), 1996. EPA Takes Final Step in Phaseout of Leaded Gasoline, [EPA press release-January 29, 1996]. Available from www.epa.gov/history/topics/lead/02.htm.
347. US EPA (U.S. Environmental Protection Agency), 1997. Exposure Factors Handbook. Vol 2: PB98–124233–Food Ingestion Factors. Chapter 14: Breast Milk Intake. EPA/600/P-95/002Fa:1-8. Washington, DC:U.S. Environmental Protection Agency.
348. US EPA (U.S. Environmental Protection Agency), 2000. Lead compounds. Available from www.epa.gov/ttn/atw/hlthef/lead.html.
349. US EPA (U.S. Environmental Protection Agency), 2004. IRIS Integrated Risk Information System, Lead and compounds (inorganic) (CASRN 7439–92-1). Available from www.epa.gov/ncea/iris/subst/0277.htm#noncar.
350. US EPA (U.S. Environmental Protection Agency), 2009. Guidance Manual for the Integrated Exposure Uptake Biokinetic Model for Children. Publication Number 9285.7–215-1, EPA 540-R-93-081, PB93-963510. February 1994. Version 1.1.
351. US FDA (U.S. Federal and Drug Administration), 1993. US FDA CSFAN Federal Register, vol. 58, p. 33860, June 21, 1993.
352. Vallee BL and Ulmer DD, 1972. Biochemical effects of mercury, cadmium, and lead. Annual Review of Biochemistry, 41, 91–128.
353. Vaziri ND, 2008. Mechanisms of lead-induced hypertension and cardiovascular disease. American Journal of Physiology Heart and Circulatory Physiology, 295, H454–465.
354. Vaziri ND, Ding Y, Ni Z and Gonick HC, 1997. Altered nitric oxide metabolism and increased oxygen free radical activity in lead-induced hypertension: effect of lazaroid therapy. Kidney International, 52, 1042–1046.
355. Vaziri ND and Sica DA, 2004. Lead-induced hypertension: role of oxidative stress. Current Hypertension Reports, 6, 314–320.
356. Verberk MM, Willems TE, Verplanke AJ and De Wolff FA, 1996. Environmental lead and renal effects in children. Archives of Environment Health, 51, 83–87.
357. Verina T, Rohde CA and Guilarte TR, 2007. Environmental lead exposure during early life alters granule cell neurogenesis and morphology in the hippocampus of young adult rats. Neuroscience, 145, 1037–1047.
358. Vermeir G, Viaene M, Staessen J, Hond ED and Roels H, 2005. Neurobehavioural investigations in adolescents exposed to environmental pollutants. Environmental Toxicology and Pharmacology, 19, 707–713.
359. Victery W, 1988. Evidence for effects of chronic lead exposure on blood pressure in experimental animals: an overview. Environmental Health Perspectives, 78, 71–76.
360. Victery W, Vander AJ, Markel H, Katzman L, Shulak JM and Germain C, 1982. Lead exposure, begun in utero, decreases renin and angiotensin II in adult rats. Proceedings of The Society for Experimental Biology and Medicine, 170, 63–67.
361. von Storch H, Costa-Cabral M, Hagner C, Feser F, Pacyna J, Pacyna E and Kolb S, 2003. Four decades of gasoline lead emissions and control policies in Europe: a retrospective assessment. Science of the Total Environment, 311, 151–176.
362. Vupputuri S, He J, Muntner P, Bazzano LA, Whelton PK and Batuman V, 2003. Blood lead level is associated with elevated blood pressure in blacks. Hypertension, 41, 463–468.
363. Waalkes MP, Diwan BA, Ward JM, Devor DE and Goyer RA, 1995. Renal tubular tumors and atypical hyperplasias in B6C3F1 mice exposed to lead acetate during gestation and lactation occur with minimal chronic nephropathy. Cancer Research, 55, 5265–5271.
364. Waalkes MP, Liu J, Goyer RA and Diwan BA, 2004. Metallothionein-I/II double knockout mice are hypersensitive to lead-induced kidney carcinogenesis: role of inclusion body formation. Cancer Research, 64, 7766–7772.
365. Wadge A and Hutton M, 1987. The leachability and chemical speciation of selected trace elements in fly ash from coal combustion and refuse incineration. Environmental Pollution, 48, 85–99.
366. Walkowiak J, Altmann L, Kramer U, Sveinsson K, Turfeld M, Weishoff-Houben M and Winneke G, 1998. Cognitive and sensorimotor functions in 6-year-old children in relation to lead and mercury levels: adjustment for intelligence and contrast sensitivity in computerized testing. Neurotoxicology and Teratology, 20, 511–521.
367. Wang HL, Chen XT, Yang B, Ma FL, Wang S, Tang ML, Hao MG and Ruan DY, 2008. Case-control study of blood lead levels and attention deficit hyperactivity disorder in Chinese children. Environmental Health Perspectives, 116, 1401–1406.
368. Warren MJ, Cooper JB, Wood SP and Shoolingin-Jordan PM, 1998. Lead poisoning, haem synthesis and 5-aminolaevulinic acid dehydratase. Trends in Biochemical Sciences, 23, 217–221.
369. Watson WS, Morrison J, Bethel MI, Baldwin NM, Lyon DT, Dobson H, Moore MR and Hume R, 1986. Food iron and lead absorption in humans. American Journal of Clinical Nutrition, 44, 248–256.
370. Watts SW, Chai S and Webb RC, 1995. Lead acetate-induced contraction in rabbit mesenteric artery: interaction with calcium and protein kinase C. Toxicology, 99, 55–65.
371. Weisskopf MG, Proctor SP, Wright RO, Schwartz J, Spiro A, 3rd Sparrow D, Nie H and Hu H, 2007. Cumulative lead exposure and cognitive performance among elderly men. Epidemiology, 18, 59–66.
372. Weisskopf MG, Wright RO, Schwartz J, Spiro A, 3rd Sparrow D, Aro A and Hu H, 2004. Cumulative lead exposure and prospective change in cognition among elderly men: the VA Normative Aging Study. American Journal of Epidemiology, 160, 1184–1193.
373. Wennberg M, Lundh T, Bergdahl IA, Hallmans G, Jansson JH, Stegmayr B, Custodio HM and Skerfving S, 2006. Time trends in burdens of cadmium, lead, and mercury in the population of northern Sweden. Environmental Research, 100, 330–338.
374. Wetmur JG, Lehnert G and Desnick RJ, 1991. The delta-aminolevulinate dehydratase polymorphism: higher blood lead levels in lead workers and environmentally exposed children with the 1–2 and 2–2 isozymes. Environmental Research, 56, 109–119.
375. White LD, Cory-Slechta DA, Gilbert ME, Tiffany-Castiglioni E, Zawia NH, Virgolini M, Rossi-George A, Lasley SM, Qian YC and Basha MR, 2007. New and evolving concepts in the neurotoxicology of lead. Toxicology and Applied Pharmacology, 225, 1–27.
376. WHO (World Health Organization), 1972. Safety evaluation of certain food additives and contaminants. WHO Food Additives Series 4: Lead. Available from www.inchem.org/documents/jecfa/jecmono/v004je03.htm.
377. WHO (World Health Organization), 1978. Safety evaluation of certain food additives and contaminants. WHO Food Additives Series 13: Lead. Available from www.inchem.org/documents/jecfa/jecmono/v13je13.htm.
378. WHO (World Health Organization), 1986. WHO 1986. Lead (evaluation of health risk to infants and children). Available from www.inchem.org/documents/jecfa/jecmono/v21je16.htm.
379. WHO (World Health Organization), 1993. Evaluation of certain food additives and contaminants. Forty-first report of the Joint FAO/WHO Expert Committee on Food Additives. WHO Technical Report Series, No. 837, Geneva.
380. WHO (World Health Organization), 1995. Environmental health criteria 165. Inorganic Lead. Lead. Available from www.inchem.org/documents/ehc/ehc/ehc165.htm.
381. WHO (World Health Organization), 2000a. Air Quality Guidelines for Europe. Second Edition. WHO Regional Publications, European Series, No 91. Copenhagen.
382. WHO (World Health Organization), 2000b. Safety evaluation of certain food additives and contaminants. WHO Food Additives Series 44: Lead. Available from www.inchem.org/documents/jecfa/jecmono/v44jec12.htm.
383. WHO (World Health Organization), 2003. Instructions for electronic submission of data on chemical contaminants in food and the diet. Global Environment Monitoring System – Food Contamination Monitoring and Assessment Programme (GEMS/Food). Available from www.who.int/foodsafety/publications/chem/en/gemsmanual.pdf. 160 pp.
384. WHO (World Health Organization), 2007. Health risks of heavy metals from long-range transboundary air pollution. Joint WHO/Convention Task Force on the Health Aspects of Air Pollution, Copenhagen.
385. WHO (World Health Organization), 2009. Toxicological and Health aspects of melamine and cyanuric acid. Report of a WHO expert meeting in collaboration with FAO. Supported by Health Canada.
386. WHO/IPCS (World Health Organization/ International Programme on Chemical Safety), 1989. Lead - environmental aspects. Environmental Health Criteria 85.
387. WHO/IPCS (World Health Organization/ International Programme on Chemical Safety), 1995. Environmental Health Criteria 165. Inorganic lead. Geneva.
388. WHO/IPCS (World Health Organization/ International Programme on Chemical Safety), 2008. Part 1: Guidance document on characterizing and communicating uncertainty in exposure assessment. Available from www.who.int/ipcs/methods/harmonization/areas/uncertainty%20.pdf.
389. Wilhelm M, Wittsiepe J, Schrey P, Hilbig A and Kersting M, 2005. Consumption of homegrown products does not increase dietary intake of arsenic, cadmium, lead, and mercury by young children living in an industrialized area of Germany. Science of the Total Environment, 343, 61–70.
390. Wright JP, Dietrich KN, Ris MD, Hornung RW, Wessel SD, Lanphear BP, Ho M and Rae MN, 2008. Association of prenatal and childhood blood lead concentrations with criminal arrests in early adulthood. PLoS Medicine, 5, e101.
391. Wu J, Basha MR, Brock B, Cox DP, Cardozo-Pelaez F, McPherson CA, Harry J, Rice DC, Maloney B, Chen D, Lahiri DK and Zawia NH, 2008a. Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD. Journal of Neuroscience, 28, 3–9.
392. Wu J, Basha MR and Zawia NH, 2008b. The environment, epigenetics and amyloidogenesis. Journal of Molecular Neuroscience, 34, 1–7.
393. Xie YX, Chiba M, Shinohara A, Watanabe H and Inaba Y, 1998. Studies on lead-binding protein and interaction between lead and selenium in the human erythrocytes. Industrial Health, 36, 234–239.
394. Yuan X and Tang C, 2001. The accumulation effect of lead on DNA damage in mice blood cells of three generations and the protection of selenium. Journal of Environmental Science and Health. Part A, Toxic/Hazardous Substances & Environmental Engineering, 36, 501–508.
395. Zawia NH, Crumpton T, Brydie M, Reddy GR and Razmiafshari M, 2000. Disruption of the zinc finger domain: a common target that underlies many of the effects of lead. Neurotoxicology, 21, 1069–1080.
396. Zawia NH, Lahiri DK and Cardozo-Pelaez F, 2009. Epigenetics, oxidative stress, and Alzheimer disease. Free Radical Biology & Medicine, 46, 1241–1249.
397. Ziegler EE, Edwards BB, Jensen RL, Mahaffey KR and Fomon SJ, 1978. Absorption and retention of lead by infants. Pediatric Research, 12, 29–34.